Edwards Lifesciences Corp (EW) Stock Price

EWStock

$90.87+10.60%52W

Market Cap$52.38B

P/E50.10x

PEG Ratio2.16

Div yield—

Beta0.85

EW Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)3.34%

Price vs S&P 500 (4W)5.10%

PEG Ratio2.16

VGM Score44.69

P/E Ratio (Annual)50.10x

P/CF (Annual)33.71x

Book Value / Share (Quarterly)$18.41

P/TBV (Annual)5.37x

Revenue Growth (3Y)4.08%

Cash Flow / Share (Quarterly)$2.49

Price vs S&P 500 (YTD)-5.80%

Gross Margin (TTM)77.84%

Net Profit Margin (TTM)15.43%

EPS (TTM)$1.73

10-Day Avg Trading Volume2.77M

EPS Excl Extra (TTM)$1.73

Revenue Growth (5Y)6.70%

EPS (Annual)$1.83

ROI (Annual)9.82%

Gross Margin (Annual)78.01%

Net Profit Margin (5Y Avg)34.96%

Cash / Share (Quarterly)$7.38

P/E Basic Excl Extra (TTM)53.52x

Revenue Growth QoQ (YoY)13.63%

EPS Growth (5Y)7.06%

P/E Normalized (Annual)50.10x

ROA (Last FY)7.84%

Revenue Growth TTM (YoY)14.55%

EBITD / Share (TTM)$2.32

ROE (5Y Avg)25.04%

Operating Margin (TTM)18.21%

Cash Flow / Share (Annual)$2.30

P/B Ratio5.06x

P/B Ratio (Quarterly)4.91x

Net Income / Employee (Annual)$67,100

EV / Revenue (TTM)7.90x

Net Interest Coverage (TTM)3.15x

ROA (TTM)7.42%

EPS Growth QoQ (YoY)-26.11%

EV / EBITDA (TTM)38.10x

EPS Incl Extra (Annual)$1.83

Current Ratio (Annual)3.72x

Quick Ratio (Quarterly)3.69x

3-Month Avg Trading Volume4.86M

52-Week Price Return10.60%

EV / Free Cash Flow (Annual)38.55x

P/E Incl Extra (TTM)53.52x

Revenue / Employee (TTM)$407,000

Tangible BV / Share (Quarterly)$16.02

P/S Ratio (Annual)8.86x

Asset Turnover (Annual)0.44x

52-Week High$96.29

Operating Margin (5Y Avg)25.36%

EPS Excl Extra (Annual)$1.83

CapEx CAGR (5Y)-8.57%

Tangible BV CAGR (5Y)16.76%

26-Week Price Return14.59%

Quick Ratio (Annual)3.02x

13-Week Price Return8.77%

Total Debt / Equity (Annual)0.06x

Current Ratio (Quarterly)4.52x

Enterprise Value$51.47B

Revenue / Share Growth (5Y)8.33%

Asset Turnover (TTM)0.48x

Book Value / Share Growth (5Y)19.43%

Revenue / Employee (Annual)$379,200

Inventory Turnover (Annual)1.21x

Pretax Margin (Annual)20.98%

Cash / Share (Annual)$7.28

3-Month Return Std Dev24.48%

Gross Margin (5Y Avg)74.05%

Net Income / Employee (TTM)$62,800

EBITDA CAGR (5Y)4.86%

EBITDA Interim CAGR (5Y)-2.24%

ROE (Last FY)10.38%

Net Interest Coverage (Annual)110.03x

EPS Basic Excl Extra (Annual)$1.83

P/FCF (TTM)36.97x

Receivables Turnover (TTM)8.88x

EV / Free Cash Flow (TTM)35.90x

Total Debt / Equity (Quarterly)0.06x

EPS Incl Extra (TTM)$1.73

Receivables Turnover (Annual)9.57x

ROI (TTM)9.16%

P/S Ratio (TTM)8.26x

Pretax Margin (5Y Avg)26.61%

Revenue / Share (Annual)$10.36

Tangible BV / Share (Annual)$15.86

Forward P/E30.28x

Free OCF CAGR (5Y)15.59%

Price vs S&P 500 (52W)-7.72%

P/E Ratio (TTM)53.52x

EPS Growth TTM (YoY)-75.18%

Year-to-Date Return6.16%

5-Day Price Return-0.53%

EPS Normalized (Annual)$1.83

ROA (5Y Avg)18.17%

Net Profit Margin (Annual)17.69%

Month-to-Date Return5.15%

Cash Flow / Share (TTM)$2.57

EBITD / Share (Annual)$2.17

EPS Growth (3Y)-9.08%

Operating Margin (Annual)18.41%

LT Debt / Equity (Annual)0.06x

P/CF (TTM)31.26x

ROI (5Y Avg)23.14%

P/E Excl Extra (TTM)53.52x

LT Debt / Equity (Quarterly)0.06x

EPS Basic Excl Extra (TTM)$1.73

P/TBV (Quarterly)5.64x

P/B Ratio (Annual)4.79x

Inventory Turnover (TTM)1.27x

Pretax Margin (TTM)21.77%

Book Value / Share (Annual)$17.80

Price vs S&P 500 (13W)5.98%

Net Margin Growth (5Y)-1.18%

Beta0.85x

P/FCF (Annual)40.28x

Revenue / Share (TTM)$11.27

ROE (TTM)9.69%

52-Week Low$72.30

vGradeD

gGradeC

mGradeB

vgmGradeC

EW Earnings Surprise History

Q2 250.67est. 0.62

Q3 250.67est. 0.59

Q4 250.58est. 0.62

Q1 260.78est. 0.73

Q2 260.78est. 0.74

EW Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.02

4.00

4.08

Industry Peers — Orthopedic & Prosthetic Devices(33)

Symbol	Value Score	Growth Score	Momentum Score	Price
EWEdwards Lifesciences Corp	D	C	B	$90.87
ISRGIntuitive Surgical Inc.	D	B	D	$371.84
STESTERIS plc	C	B	C	$236.44
ZBHZimmer Biomet Holdings, Inc.	B	C	C	$100.24
SNNSmith & Nephew plc	B	C	D	$29.22
ALGNAlign Technology Inc	B	D	C	$159.61
MSAMine Safety Incorporated	C	C	C	$187.69
ESTAEstablishment Labs Holdings Inc.	F	A	C	$72.15
ENOVEnovis Corporation	B	D	C	$25.58
CDRECadre Holdings, Inc.	C	C	C	$31.39
AVNSAvanos Medical, Inc.	B	D	C	$24.99
AVRAnteris Technologies Global Corp. Common Stock	F	D	B	$8.89
SMTISanara MedTech Inc. Common Stock	D	C	B	$34.67
ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares	B	D	C	$2.77
CNXUConexeu Sciences Inc. Common Stock	—	—	F	$7.55
INGNInogen Inc	B	D	D	$5.54
LAKELakeland Industries Inc	B	D	C	$11.52
SPAISafe Pro Group Inc. Common Stock	F	C	B	$5.25
NTRBNutriband Inc. Common Stock	F	D	B	$4.83
MYOMyomo Inc.	C	B	B	$1.48
COCHEnvoy Medical, Inc. Class A Common Stock	D	D	C	$0.75
APTAlpha Pro Tech, Ltd.	A	D	C	$5.36
MLSSMilestone Scientific, Inc. Common Stock	D	D	B	$0.48
LFWDLifeward Ltd. Ordinary Shares	B	D	C	$7.39
RGNTRegentis Biomaterials Ltd.	—	—	C	$2.09
HSCSHeartSciences Inc. Common Stock	F	F	B	$3.00
CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares	—	D	C	$2.92
CLGNCollPlant Biotechnologies Ltd Ordinary Shares	C	F	F	$0.29
FEEDENvue Medical, Inc. Common Stock	A	F	F	$0.39
BBLGBone Biologics Corp Common Stock	—	—	F	$0.60
BBLGWBone Biologics Corp Warrants	—	—	D	$8.24
COCHWEnvoy Medical, Inc Warrant	—	—	F	$0.04
HSCSWHeartSciences Inc. Warrant	—	—	F	$0.04
NTRBWNutriband Inc. Warrant	—	—	D	$0.50

About Edwards Lifesciences Corp

Edwards Lifesciences is a global leader in medical devices for treating structural heart disease, specializing in surgical tissue heart valves and transcatheter valve replacement technologies. Spun off from Baxter International in 2000, the company has established dominant market positions across aortic, mitral, and tricuspid valve solutions. With approximately 60% of revenues from international markets, Edwards benefits from strong geographic diversification in the growing structural heart disease treatment sector.